The TCR therapy drug pipeline is advancing rapidly, focusing on engineered T-cell receptors to target cancer-specific antigens, offering promising personalized immunotherapy options. https://www.expertmarketresearch.com/clinical-trials/tcr-therapy-drug-pipeline-insight